CNS Pharmaceuticals Files 2024 10-K
Ticker: CNSP · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1729427
| Field | Detail |
|---|---|
| Company | Cns Pharmaceuticals, Inc. (CNSP) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
CNS Pharma filed its 2024 10-K. Full financials and ops details are in.
AI Summary
CNS Pharmaceuticals, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Nevada and headquartered in Houston, TX, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of CNS Pharmaceuticals' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, CNS Pharmaceuticals faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in their 10-K filing.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (For comparative financial analysis)
- 2022 — Prior Fiscal Year (For comparative financial analysis)
Key Players & Entities
- CNS Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- Houston, TX (location) — Company headquarters
FAQ
What is the primary business of CNS Pharmaceuticals, Inc.?
CNS Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted on March 31, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Where is CNS Pharmaceuticals, Inc. headquartered?
CNS Pharmaceuticals, Inc. is headquartered in Houston, TX.
What is the state of incorporation for CNS Pharmaceuticals, Inc.?
CNS Pharmaceuticals, Inc. is incorporated in Nevada (NV).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding CNS Pharmaceuticals, Inc. (CNSP).